United States Spatial Genomics and Transcriptomics Market expected to grow at a CAGR of 9.35% during 2024-2031 | Major Compnies 2026 - NanoString Technologies Inc, S2 Genomics Inc, Akoya Biosciences

Leander, Texas and Tokyo, Japan - Jan.08.2026
As per DataM intelligence research report" Spatial Genomics and Transcriptomics Market is estimated to reach USD million by 2031, growing at a CAGR of 9.35% during the forecast period (2024-2031)." Precision medicine and advanced cancer research are accelerating adoption.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/spatial-genomics-and-transcriptomics-market?prasad

United States Recent Industry Developments

✅ In November 2025, 10x Genomics launched the "Visium HD" platform with single-cell resolution The technology allows researchers to map gene expression to specific cells within tissue architecture It advances the understanding of tumor microenvironments in U.S. cancer research

✅ In October 2025, NanoString Technologies (Bruker) introduced a high-plex protein and RNA panel The panel enables the simultaneous detection of hundreds of biomarkers on a single slide It supports multi-omics studies in U.S. academic centers

✅ In September 2025, A U.S. startup released a "Benchtop" spatial sequencer for pathology labs The compact device makes spatial biology accessible to routine diagnostic workflows It democratizes advanced tissue analysis for U.S. hospitals

✅ In August 2025, The Broad Institute published a new computational method for spatial transcriptomics The algorithm reconstructs gene expression maps without expensive imaging equipment It lowers the cost barrier for spatial research in the U.S.

Japan Recent Industry Developments

✅ In December 2025, Takara Bio launched a service for spatial gene expression analysis The service processes tissue samples from researchers to provide spatial maps It supports Japanese pharmaceutical companies in drug target discovery

✅ In November 2025, Fujifilm Wako Pure Chemical introduced reagents optimized for spatial tissue clearing The reagents make tissues transparent for 3D spatial analysis It aids in the mapping of complex structures like the brain in Japanese neuroscience

✅ In October 2025, A Japanese university developed a new slide-free spatial technology The method captures RNA from tissue directly onto a functionalized surface It simplifies the workflow for spatial transcriptomics in Japan

✅ In September 2025, The National Cancer Center Japan initiated a spatial biology atlas of gastric cancer The project maps the immune landscape of stomach tumors to predict drug response It leverages spatial tech to tackle a prevalent cancer in Japan

Spatial Genomics and Transcriptomics Market: Drivers
The spatial genomics and transcriptomics market is growing due to advances in precision medicine. Demand for tissue-level molecular insights supports adoption. Technological advancements improve resolution and accuracy. Expansion of cancer and neuroscience research drives growth. Academic and pharmaceutical investments strengthen development. Regulatory support enables innovation.

Market growth is reinforced by integration with AI analytics. Emerging markets expand genomics research. Collaborations between research institutes and biotech firms accelerate innovation. Increasing use in drug discovery boosts demand. Personalized medicine trends support growth. Spatial genomics is transforming biomedical research.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/spatial-genomics-and-transcriptomics-market?prasad

Spatial Genomics and Transcriptomics Market: Major Players
NanoString Technologies Inc, S2 Genomics Inc, Akoya Biosciences, ION path Inc, Fluidigm Corporation, 10X Genomics Inc, BioSpyder Technologies, Rebus Biosystems LLC, Resolve Biosciences, Vizgen Corporation.

Segment Covered in the Spatial Genomics and Transcriptomics Market:
By Technique
The market is segmented into spatial transcriptomics 30%, immunohistochemistry (IHC) 15%, in situ hybridization 10%, sequencing technologies 15%, microscopy-based RNA imaging 10%, and others 5%. For spatial genomics, fluorescence in situ hybridization (FISH) 10%, sequencing techniques 5%, and others 5%. Spatial transcriptomics dominates due to its ability to map gene expression within tissue context, providing critical insights in cancer, neuroscience, and developmental biology research. FISH and sequencing-based spatial genomics are growing rapidly in precision research and diagnostics.

By Product
Based on product, the market includes instruments 40%, consumables 35%, and software 25%. Instruments dominate due to high investment in advanced imaging, sequencing, and tissue processing platforms. Consumables support high-throughput workflows and experiments, while software is critical for data analysis, visualization, and spatial mapping of transcriptomic information.

By End-User
End-users include academic & research institutes 40%, contract research organizations (CROs) 25%, pharmaceutical & biotechnology companies 25%, and others 10%. Academic and research institutes lead due to extensive adoption in fundamental research, tissue atlases, and spatial biology studies. CROs and pharma/biotech firms are increasingly adopting these techniques for drug discovery, biomarker identification, and therapeutic development.

Regional Analysis
North America - 35% Share
North America leads with 35% share driven by strong R&D investment, advanced research infrastructure, and adoption of cutting-edge spatial genomics and transcriptomics technologies in the U.S. and Canada.

Europe - 25% Share
Europe accounts for 25% share supported by government research funding, genomic research initiatives, and widespread use in academic and pharmaceutical research across Germany, the UK, and France.

Asia Pacific - 25% Share
Asia Pacific holds 25% share with growing life sciences research, increasing pharmaceutical R&D, and expansion of biotech companies in China, Japan, India, and South Korea.

Latin America - 8% Share
Latin America represents 8% share driven by emerging adoption of genomics technologies in research institutions and pharmaceutical collaborations in Brazil, Mexico, and Argentina.

Middle East & Africa - 7% Share
Middle East & Africa accounts for 7% share, supported by investments in advanced life sciences research infrastructure, genomics initiatives, and biotechnology adoption in UAE, Saudi Arabia, and South Africa.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=spatial-genomics-and-transcriptomics-market

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.